US pharmacy pricing
Rivive Cost Without Insurance — US Pharmacy Price Guide
Lowest price found · US pharmacies
$32.34/fill
for Rivive, across the pharmacies in our data
US pharmacy prices — 2 liquid
| Pharmacy | Discount-card price | Regular cash price | Average retail |
|---|---|---|---|
 Kroger Pharmacy | $32.34Lowest | $35.34 | $8.49 |
 Harris Teeter Pharmacy | $32.34Lowest | $35.34 | $8.49 |
 Costco | $33.68 | $36.68 | $8.49 |
 Publix | $35.96 | $38.96 | $8.49 |
 Food Lion | $38.60 | $38.60 | $8.49 |
"Discount-card price" reflects a standard prescription discount card, not insurance. Prices change often — confirm at the pharmacy before filling.
Interchangeable forms
Per RxNorm (U.S. National Library of Medicine), these share the same active ingredient and strength as Rivive.
Frequently asked questions
Is Rivive (Rivive) expensive if I don't have insurance?
At the US pharmacies in our data, the lowest listed discount-card price for Rivive is around $32.34. Prices vary by pharmacy, dosage, and pack size, so use the table above to compare specific options near you.
Is a generic version of Rivive available?
Generic and brand-name pricing for Rivive is broken out in the tables above where both exist in our data. Generic versions are typically the lower-cost option, but availability depends on the specific formulation and dosage.
What is the cost of RiVive with insurance coverage?
Insurance coverage for RiVive varies significantly by plan. To determine your specific cost, you should contact your insurance provider directly for details on formulary status and copay amounts. If your plan does not cover RiVive, or if you are enrolled in Medicare or Medicaid, you may be able to use independent pharmacy savings programs to obtain a discount. It can be helpful to compare the price available through such a program with your insurance copay to find the most affordable option.
Is there a generic version of RiVive?
No. RiVive is currently only available as a brand-name product manufactured by Harm Reduction Therapeutics, and a generic equivalent has not been approved.